PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • 24-hour nicotine patch - Market size and forecast 2018-2023 • 16-hour nicotine patch - Market size and forecast 2018-2023 • Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • APAC - Market size and forecast 2018-2023 • South America - Market size and forecast 2018-2023 • MEA - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Online retailing • Rising number of promotional campaigns and activities for smoking cessation aids • Technological innovations in transdermal drug delivery process PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Dr. Reddy’s Laboratories Ltd. • GlaxoSmithKline plc. • Johnson & Johnson Services, Inc. • Novartis AG • Perrigo Company plc PART 14: APPENDIX • Research methodology • List of abbreviations PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global tobacco market Exhibit 02: Segments of global tobacco market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global nicotine patch market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global nicotine patch market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: Product - Market share 2018-2023 (%) Exhibit 18: Comparison by product Exhibit 19: -hour nicotine patch - Market size and forecast 2018-2023 ($ millions) Exhibit 20: -hour nicotine patch - Year-over-year growth 2019-2023 (%) Exhibit 21: -hour nicotine patch - Market size and forecast 2018-2023 ($ millions) Exhibit 22: -hour nicotine patch - Year-over-year growth 2019-2023 (%) Exhibit 23: Market opportunity by product Exhibit 24: Customer landscape Exhibit 25: Market share by geography 2018-2023 (%) Exhibit 26: Comparison by geography Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 28: North America - Year-over-year growth 2019-2023 (%) Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 30: Europe - Year-over-year growth 2019-2023 (%) Exhibit 31: APAC - Market size and forecast 2018-2023 ($ millions) Exhibit 32: APAC - Year-over-year growth 2019-2023 (%) Exhibit 33: South America - Market size and forecast 2018-2023 ($ millions) Exhibit 34: South America - Year-over-year growth 2019-2023 (%) Exhibit 35: MEA - Market size and forecast 2018-2023 ($ millions) Exhibit 36: MEA - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Dr. Reddy’s Laboratories Ltd. - Vendor overview Exhibit 46: Dr. Reddy’s Laboratories Ltd. - Business segments Exhibit 47: Dr. Reddy’s Laboratories Ltd. - Organizational developments Exhibit 48: Dr. Reddy’s Laboratories Ltd. - Geographic focus Exhibit 49: Dr. Reddy’s Laboratories Ltd. - Segment focus Exhibit 50: Dr. Reddy’s Laboratories Ltd. - Key offerings Exhibit 51: GlaxoSmithKline plc. - Vendor overview Exhibit 52: GlaxoSmithKline plc. - Business segments Exhibit 53: GlaxoSmithKline plc. - Organizational developments Exhibit 54: GlaxoSmithKline plc. - Geographic focus Exhibit 55: GlaxoSmithKline plc. - Segment focus Exhibit 56: GlaxoSmithKline plc. - Key offerings Exhibit 57: Johnson & Johnson Services, Inc. - Vendor overview Exhibit 58: Johnson & Johnson Services, Inc. - Business segments Exhibit 59: Johnson & Johnson Services, Inc. - Organizational developments Exhibit 60: Johnson & Johnson Services, Inc. - Geographic focus Exhibit 61: Johnson & Johnson Services, Inc. - Segment focus Exhibit 62: Johnson & Johnson Services, Inc. - Key offerings Exhibit 63: Novartis AG - Vendor overview Exhibit 64: Novartis AG - Business segments Exhibit 65: Novartis AG - Organizational developments Exhibit 66: Novartis AG - Geographic focus Exhibit 67: Novartis AG - Segment focus Exhibit 68: Novartis AG - Key offerings Exhibit 69: Perrigo Company plc - Vendor overview Exhibit 70: Perrigo Company plc - Business segments Exhibit 71: Perrigo Company plc - Organizational developments Exhibit 72: Perrigo Company plc - Geographic focus Exhibit 73: Perrigo Company plc - Segment focus Exhibit 74: Perrigo Company plc - Key offerings Exhibit 75: Validation techniques employed for market sizing    

Dr. Reddy’s Laboratories Ltd. GlaxoSmithKline plc. Johnson & Johnson Services Inc. Novartis AG Perrigo Company plc.